MacLaren, Robert E. http://orcid.org/0000-0002-3096-4682
Fischer, M. Dominik
Gow, James A.
Lam, Byron L.
Sankila, Eeva-Marja K.
Girach, Aniz
Panda, Sushil
Yoon, Dan
Zhao, Guolin
Pennesi, Mark E.
Funding for this research was provided by:
This study was funded by Biogen.
Article History
Received: 9 December 2022
Accepted: 28 July 2023
First Online: 9 October 2023
Competing interests
: R.E.M. and M.D.F. have received grant support, clinical trial support and consultancy fees from Biogen. R.E.M. is a named inventor on the BIIB111 patent licensed by the University of Oxford. B.L.L. has received grant support and consultancy fees from Biogen. E.-M.K.S. has received clinical trial support from Biogen. A.G. was an employee of Nightstar at the time of the study. J.A.G., S.P., D.Y. and G.Z. were employees of Biogen at the time of the study and may hold stock in the company. M.E.P. has received consultancy fees from Biogen and grant funding from Research to Prevent Blindness (New York) to Casey Eye Institute (unrestricted grant).